new
center

Global Urokinase Raw Material Market Expected to Reach USD 120 Million by 2032

2026-9-22

According to QYResearch data, the global urokinase raw material market reached USD 82 million in 2025 and is projected to grow to USD 120 million by 2032, with a CAGR of 5.2% during 2026–2032. The market is segmented by product type (human urine-derived and recombinant production) and application (hospitals, clinics, others). Key regions include the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The report highlights overseas expansion opportunities for Chinese urokinase raw material enterprises.

PrevThe National Healthcare Security Administration held a symposium for pharmaceutical companies to discuss the high standards for the "15th Five Year Plan"; Quality DevelopmentNextChinese Urokinase Manufacturers Optimize Virus Inactivation and Traceability to Meet International Standards
company logo
Breakthrough through scientific research to extract difficult problems
Massive production and partners to expand the vast world together
Home Home product product hotline hotline